Carastock.

Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $152.77M. -68.8%. Market Cap / Employee. The market cap of a ...Dec 1, 2023 · Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company’s lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults ... Real time Cara Therapeutics (CARA) stock price quote, stock graph, news & analysis.Feb 12, 2014 · Post #2,000. Item 8.01 Other Information. As previously disclosed, on August 23, 2021, Cara Therapeutics, Inc. (“Cara”) received approval of its New Drug Application for KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients from the U.S. Food and Drug Administration (the “Approval Milestone”). What is the CARA Therapeutics stock forecast? · CARA Therapeutics stock prediction for 1 year from now: $ 7.69 (625.24%) · CARA Therapeutics stock forecast for ...

Track Cara Therapeutics Inc (CARA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Find the latest Cara Therapeutics, Inc. (CARA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Stock Price Forecast. According to 8 stock analysts, the average 12-month stock price forecast for CARA stock stock is $15.13, which predicts an increase of …Pruritus is defined as an unpleasant sensation that provokes the desire to scratch, but we know it’s much more than that. Chronic pruritus can be a devastating, disabling, and burdensome condition that significantly impairs quality of life. The millions of people who suffer from pruritus deserve relief.Sep 18, 2023 · The 39 rating InvestorsObserver gives to Cara Therapeutics Inc ( CARA) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 41 percent of stocks in the Biotechnology industry, CARA’s 39 overall rating means the stock scores better than 39 percent of all stocks. CARA has an Overall Score of 39. Cara Therapeutics Inc (CARA) stock is trading at $4.98 as of 3:31 PM on Thursday, Mar 23, a decline of -$0.20, or -3.86% from the previous closing price of $5.18. The stock has traded between $4.94 and $5.33 so far today. Volume today is below average. So far 419,735 shares have traded compared to average volume of 832,550 shares.Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company’s lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults ...

Cara Therapeutics Inc ( CARA) has risen Tuesday morning, with the stock increasing 5.25% in pre-market trading to 3.41. CARA's short-term technical score of 10 indicates that the stock has traded less bullishly over the last month than 90% of stocks on the market. In the Biotechnology industry, which ranks 110 out of 146 industries, the stock ...

The latest analyst coverage could presage a bad day for Cara Therapeutics, Inc. (NASDAQ:CARA), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little shell-shocked.Revenue and earnings per share (EPS) forecasts were both revised downwards, with analysts seeing grey clouds …

Trailing 12-Months. Asset Growth. -40.69%. Trailing 12-Months. Cara Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven ...Apr 24, 2023 · Cara Therapeutics' current financial performance and market outlook do not paint an encouraging picture for investors. Find out why CARA stock is a Sell. Cara Therapeutics Stock Earnings. The value each CARA share was expected to gain vs. the value that each CARA share actually gained. Cara Therapeutics ( CARA) reported Q3 2023 earnings per share (EPS) of -$0.52, meeting estimates of -$0.52 by 0.60%. In the same quarter last year, Cara Therapeutics 's earnings per share (EPS) was -$0.43.10 thg 4, 2015 ... Shares of Cara began trading publicly for the first time in more than a decade on Friday and quickly jumped about 40 per cent above the ...1. Rumus Safety Stock Dasar. Opsi paling sederhana adalah mengadopsi formula persediaan cadangan yang banyak digunakan, yaitu: Safety stock = (penjualan maksimal harian x lead time maksimum) – (penjualan harian rata-rata x lead time rata-rata) Berikut adalah variabel yang masuk ke rumus ini:May 25, 2023 at 3:40 AM · 3 min read. You may think that with a price-to-sales (or "P/S") ratio of 4.4x Cara Therapeutics, Inc. ( NASDAQ:CARA) is a stock to potentially avoid, seeing as almost ...

Cara Therapeutics (CARA) Company Description. Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic ...What's Happening With CARA Stock Today? Cara Therapeutics Inc (CARA) stock is trading at $5.05 as of 2:41 PM on Friday, Mar 31, an increase of $0.16, or 3.27% from the previous closing price of $4.89. The stock has traded between $4.90 and $5.06 so far today.Cara Therapeutics Inc’s trailing 12-month revenue is $27.2 million with a -410.9% profit margin. Year-over-year quarterly sales growth most recently was -70.0%. Analysts expect adjusted earnings to reach $-1.998 per share for the current fiscal year. Cara Therapeutics Inc does not currently pay a dividend.Stock Price Forecast ... The 6 analysts offering 12-month price forecasts for Cara Therapeutics Inc have a median target of 9.50, with a high estimate of 22.00 ...Cara Therapeutics Inc (CARA) stock is higher by 5.42% while the S&P 500 is lower by -0.08% as of 1:37 PM on Thursday, Apr 7. CARA has risen $0.69 from the previous closing price of $12.73 on volume of 256,141 shares. Over the past year the S&P 500 is higher by 9.75% while CARA is lower by -49.42%.The average price recommended by analysts for Cara Therapeutics Inc (CARA) is $10.29, which is $9.33 above the current market price. The public float for CARA is 46.23M and currently, short sellers hold a 6.42% of that float. On November 24, 2023, CARA’s average trading volume was 599.48K shares. Top 5 EV Tech Stocks to Buy for …

Cara Therapeutics Inc’s trailing 12-month revenue is $27.2 million with a -410.9% profit margin. Year-over-year quarterly sales growth most recently was -70.0%. Analysts expect adjusted earnings to reach $-1.998 per share for the current fiscal year. Cara Therapeutics Inc does not currently pay a dividend.Cara Therapeutics Inc’s ( CARA) price is currently down 34.15% so far this month. During the month of March, Cara Therapeutics Inc’s stock price has reached a high of $10.39 and a low of $6.58. Over the last year, Cara Therapeutics Inc has hit prices as high as $13.97 and as low as $7.40. Year to date, Cara Therapeutics Inc’s stock is ...

Cara Therapeutics Inc (CARA) stock has fallen -6.06% while the S&P 500 has risen 0.34% as of 12:40 PM on Tuesday, Nov 7. CARA has fallen -$0.08 from the previous closing price of $1.33 on volume of 223,033 shares. Over the past year the S&P 500 has gained 15.08% while CARA has fallen -86.62%. CARA lost -$2.07 per share the …Explore new charts. Discover historical prices for CARA stock on Yahoo Finance. View daily, weekly or monthly format back to when Cara Therapeutics, Inc. stock was issued.Track Cara Therapeutics Inc (CARA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFind the latest Cara Therapeutics, Inc. (CARA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.View the latest Cara Therapeutics Inc. (CARA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Find real-time CARA - Cara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Who is on Cara Therapeutics's Insider Roster? The list of insiders at Cara Therapeutics includes Christopher Posner, Derek T Chalmers, Frederique Ph.D. Menzaghi, Jeffrey L Ives, Joana Goncalves, Martin Vogelbaum, Scott Terrillion, and Thomas Charles Reilly. Learn more on insiders at CARA.

As of Friday, March 17, Cara Therapeutics Inc’s CARA share price has dipped by 5.19%, which has investors questioning if this is right time to buy.

As of Friday, March 17, Cara Therapeutics Inc’s CARA share price has dipped by 5.19%, which has investors questioning if this is right time to buy.

CARA - Cara Therapeutics Inc - Stock screener for investors and traders, financial visualizations.Cara Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of novel therapeutics to treat serious medical conditions, including pruritus.CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs).CARA Stock 12 Months Forecast. $14.10. (1230.19% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Cara Therapeutics in the last 3 months. The average price target is $14.10 with a high forecast of $25.00 and a low forecast of $3.50. The average price target represents a 1230.19% change from the last price of $1.06.Trailing 12-Months. Asset Growth. -40.69%. Trailing 12-Months. Cara Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven ... Interactive Chart for Cara Therapeutics, Inc. (CARA), analyze all the data with a huge range of indicators.Cara Therapeutics Stock (NASDAQ: CARA) stock price, news, charts, stock research, profile.The Cara Therapeutics stock price fell by -1.90% on the last day (Wednesday, 29th Nov 2023) from $0.98 to $0.96. During the last trading day the stock fluctuated 7.37% from a day low at $0.95 to a day high of $1.02. The price has fallen in 6 of the last 10 days and is down by -12.47% for this period. Volume has increased on the last day by 227 ...

As of March 10, 2023, 4:00 PM CST, Cara Therapeutics Inc’s stock price was $6.06. Cara Therapeutics Inc is down 5.16% from its previous closing price of $6.39. During the last market session, Cara Therapeutics Inc’s stock traded between $6.24 and $6.71. Currently, there are 53.76 million shares of Cara Therapeutics Inc stock available for ...Nov 14, 2023 · The company, currently valued at $57.32M, closed the recent trade at $1.06 per share which meant it lost -$0.12 on the day or -10.17% during that session. The CARA stock price is -1108.49% off its 52-week high price of $12.81 and 2.83% above the 52-week low of $1.03. If we look at the company’s 10-day average daily trading volume, we find ... Find the latest Cara Therapeutics, Inc. (CARA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.24 thg 11, 2023 ... Quant Rating History · Go Premium to see CARA Quant Rating · Navigate the Stock Market with Seeking Alpha.Instagram:https://instagram. viper energy stockforex signal servicehome loans for people who filed bankruptcybenzinga stocks to watch Shutterstock is a global marketplace for artists and creators to sell royalty-free images, footage, vectors and illustrations. We want to see the world through your eyes.Nov 24, 2023 · The average price recommended by analysts for Cara Therapeutics Inc (CARA) is $10.29, which is $9.33 above the current market price. The public float for CARA is 46.23M and currently, short sellers hold a 6.42% of that float. On November 24, 2023, CARA’s average trading volume was 599.48K shares. Top 5 EV Tech Stocks to Buy for 2023. gulfport energy corporationmecedes amg gle According to the issued ratings of 6 analysts in the last year, the consensus rating for Cara Therapeutics stock is Moderate Buy based on the current 1 sell rating, 1 hold rating and 4 buy ratings for CARA. The average twelve-month price prediction for Cara Therapeutics is $15.86 with a high price target of $25.00 and a low price target of $4.00. best dollar stocks to buy Cara Therapeutics (CARA) Options Chain & Prices. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get daily stock ideas from top-performing Wall Street analysts.It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...